Clinical Trial Update: A Short-term Comparative Study of Aerosure for Airway Clearance in Patients With Cystic Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2 short-term comparative trial evaluating Aerosure for airway clearance in cystic fibrosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Aerosure

Snippet

Sponsor: Actegy Ltd. | Conditions: Cystic Fibrosis | Phase 2 | Status: TERMINATED